Wilson DR - Search Results

1

Local and systemic inhibition of lung tumor growth after nanoparticle-mediated mda-7/IL-24 gene delivery.

Ramesh R, Ito I, Saito Y, Wu Z, Mhashikar AM, Wilson DR, Branch CD, Roth JA, Chada S. Ramesh R, et al. Among authors: wilson dr. DNA Cell Biol. 2004 Dec;23(12):850-7. doi: 10.1089/dna.2004.23.850. DNA Cell Biol. 2004. PMID: 15684712

2

Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector.

Ramesh R, Saeki T, Templeton NS, Ji L, Stephens LC, Ito I, Wilson DR, Wu Z, Branch CD, Minna JD, Roth JA. Ramesh R, et al. Among authors: wilson dr. Mol Ther. 2001 Mar;3(3):337-50. doi: 10.1006/mthe.2001.0266. Mol Ther. 2001. PMID: 11273776 Free article.

3

Adenovirus-mediated p16INK4a gene expression radiosensitizes non-small cell lung cancer cells in a p53-dependent manner.

Kawabe S, Roth JA, Wilson DR, Meyn RE. Kawabe S, et al. Among authors: wilson dr. Oncogene. 2000 Nov 9;19(47):5359-66. doi: 10.1038/sj.onc.1203935. Oncogene. 2000. PMID: 11103937

4

Adenovirus-mediated wild-type p53 gene expression radiosensitizes non-small cell lung cancer cells but not normal lung fibroblasts.

Kawabe S, Munshi A, Zumstein LA, Wilson DR, Roth JA, Meyn RE. Kawabe S, et al. Among authors: wilson dr. Int J Radiat Biol. 2001 Feb;77(2):185-94. doi: 10.1080/09553000010008540. Int J Radiat Biol. 2001. PMID: 11236925

5

Radiosensitization of human tumor cell lines induced by the adenovirus-mediated expression of an anti-Ras single-chain antibody fragment.

Russell JS, Lang FF, Huet T, Janicot M, Chada S, Wilson DR, Tofilon PJ. Russell JS, et al. Among authors: wilson dr. Cancer Res. 1999 Oct 15;59(20):5239-44. Cancer Res. 1999. PMID: 10537303

6

Adenoviral p53 gene transfer in human bladder cancer cell lines: cytotoxicity and synergy with cisplatin.

Pagliaro LC, Keyhani A, Liu B, Perrotte P, Wilson D, Dinney CP. Pagliaro LC, et al. Urol Oncol. 2003 Nov-Dec;21(6):456-62. doi: 10.1016/s1078-1439(03)00032-2. Urol Oncol. 2003. PMID: 14693272

7

Tumor-suppressive activity of CD66a in prostate cancer.

Luo W, Tapolsky M, Earley K, Wood CG, Wilson DR, Logothetis CJ, Lin SH. Luo W, et al. Among authors: wilson dr. Cancer Gene Ther. 1999 Jul-Aug;6(4):313-21. doi: 10.1038/sj.cgt.7700055. Cancer Gene Ther. 1999. PMID: 10419049

8

Biosafety of in vivo adenovirus-p53 intravesical administration in mice.

Perrotte P, Wood M, Slaton JW, Wilson DR, Pagliaro L, Price RE, Dinney CP. Perrotte P, et al. Among authors: wilson dr. Urology. 2000 Jul;56(1):155-9. doi: 10.1016/s0090-4295(00)00537-9. Urology. 2000. PMID: 10869658

9

Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo.

Ghaneh P, Greenhalf W, Humphreys M, Wilson D, Zumstein L, Lemoine NR, Neoptolemos JP. Ghaneh P, et al. Gene Ther. 2001 Feb;8(3):199-208. doi: 10.1038/sj.gt.3301394. Gene Ther. 2001. PMID: 11313791

10

A preclinical model of minimal residual cancer in the muscle highlights challenges associated with adenovirus-mediated p53 gene transfer.

Oakley R, Phillips E, Hooper R, Wilson D, Partridge M. Oakley R, et al. Clin Cancer Res. 2002 Jun;8(6):1984-94. Clin Cancer Res. 2002. PMID: 12060644

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

530 results

Search Page

Filters